AAPL   375.51 (+0.44%)
FB   243.93 (+1.52%)
AMZN   3,039.08 (-0.59%)
NVDA   398.47 (+1.25%)
TSLA   1,396.99 (+1.85%)
ACB   12.47 (+2.38%)
GILD   76.66 (-0.13%)
BAC   23.08 (-2.45%)
NFLX   494.21 (+0.08%)
BA   182.14 (-3.07%)
AAPL   375.51 (+0.44%)
FB   243.93 (+1.52%)
AMZN   3,039.08 (-0.59%)
NVDA   398.47 (+1.25%)
TSLA   1,396.99 (+1.85%)
ACB   12.47 (+2.38%)
GILD   76.66 (-0.13%)
BAC   23.08 (-2.45%)
NFLX   494.21 (+0.08%)
BA   182.14 (-3.07%)
AAPL   375.51 (+0.44%)
FB   243.93 (+1.52%)
AMZN   3,039.08 (-0.59%)
NVDA   398.47 (+1.25%)
TSLA   1,396.99 (+1.85%)
ACB   12.47 (+2.38%)
GILD   76.66 (-0.13%)
BAC   23.08 (-2.45%)
NFLX   494.21 (+0.08%)
BA   182.14 (-3.07%)
AAPL   375.51 (+0.44%)
FB   243.93 (+1.52%)
AMZN   3,039.08 (-0.59%)
NVDA   398.47 (+1.25%)
TSLA   1,396.99 (+1.85%)
ACB   12.47 (+2.38%)
GILD   76.66 (-0.13%)
BAC   23.08 (-2.45%)
NFLX   494.21 (+0.08%)
BA   182.14 (-3.07%)
Log in

NASDAQ:EIGREiger Biopharmaceuticals Social Media Mentions

$9.52
+0.01 (+0.11 %)
(As of 07/7/2020 02:02 PM ET)
Add
Compare
Today's Range
$9.37
Now: $9.52
$9.60
50-Day Range
$9.51
MA: $11.23
$13.37
52-Week Range
$4.55
Now: $9.52
$15.82
Volume7,434 shs
Average Volume278,473 shs
Market Capitalization$238.57 million
P/E RatioN/A
Dividend YieldN/A
Beta1.48

Social Media

This page was last updated on 7/7/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.